 | Stock Traders Purchase Large Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR)
americanbankingnews.com - December 3 at 1:20 PM |
 | Esperion Announces Pricing of $225 Million Public Offering
finance.yahoo.com - December 3 at 4:07 AM |
| Why Is Esperion Therapeutics (ESPR) Down 24.5% Since Last Earnings Report?
finance.yahoo.com - December 2 at 5:19 PM |
| Esperion Announces Proposed Public Offering
finance.yahoo.com - December 2 at 5:19 PM |
| Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Rating of "Hold" by Brokerages
americanbankingnews.com - November 27 at 9:44 AM |
| Analysts Expect Esperion Therapeutics, Inc. (NASDAQ:ESPR) Will Announce Quarterly Sales of $15.09 Million
americanbankingnews.com - November 27 at 5:54 AM |
| Esperion Therapeutics, Inc. (NASDAQ:ESPR) Expected to Post Earnings of -$2.74 Per Share
americanbankingnews.com - November 25 at 5:14 AM |
 | Pre-market Movers: OCUP, KTTA, GAME, BIOL, JWN…
markets.businessinsider.com - November 24 at 8:02 AM |
| Implied Volatility Surging for Esperion Therapeutics (ESPR) Stock Options
finance.yahoo.com - November 19 at 7:56 PM |
| Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021
finance.yahoo.com - November 12 at 7:27 AM |
| Esperion Therapeutics, Inc. (NASDAQ:ESPR): Are Analysts Optimistic?
finance.yahoo.com - November 6 at 10:30 AM |
|
| Esperion (ESPR) Beats on Q3 Earnings, Lowers Expense Guidance
finance.yahoo.com - November 2 at 3:34 PM |
| Esperion Reports Third Quarter 2021 Financial Results and Provides Company Update
ca.finance.yahoo.com - November 2 at 10:34 AM |
| Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021
finance.yahoo.com - November 1 at 6:07 PM |
| Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors
finance.yahoo.com - November 1 at 8:02 AM |
| Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - October 26 at 10:14 PM |
| Why Esperion Therapeutics Plummeted by 11% Today
finance.yahoo.com - October 25 at 9:11 PM |
| ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock
finance.yahoo.com - October 25 at 11:10 AM |
| Esperion (ESPR) to Cut 40% Workforce, Revamp Cost Structure
finance.yahoo.com - October 19 at 12:28 PM |
| Esperion Plans Expense & Operational Structure Alignment; Shares Fall 1.5% Pre-Market
finance.yahoo.com - October 18 at 1:55 PM |
| ESPERION Announces Plan for Transformative Long-Term Growth
finance.yahoo.com - October 18 at 8:54 AM |
| Esperion Therapeutics to reduce workforce by 40%
finance.yahoo.com - October 18 at 8:54 AM |
| Esperion to Report Third Quarter 2021 Financial Results November 2, 2021
finance.yahoo.com - October 12 at 10:18 AM |
| Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Fourth Quarter and Full Year 2014 Financial Results
finance.yahoo.com - September 12 at 11:27 PM |
| 3 “Strong Buy” Stocks Flirting With a Bottom
finance.yahoo.com - September 9 at 11:32 AM |
| ESPERION to Host Investor Webinar on the Current Landscape and Future Directions in the Treatment of Elevated Cholesterol
finance.yahoo.com - September 7 at 7:27 PM |
| Esperion Therapeutics (ESPR) Down 5.9% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - September 2 at 6:19 PM |
| If You Had Bought Esperion Therapeutics' (NASDAQ:ESPR) Shares Three Years Ago You Would Be Down 69%
finance.yahoo.com - August 8 at 1:00 PM |
| Esperion (ESPR) Q2 Loss Narrower Than Expected, Drug Price Up
finance.yahoo.com - August 4 at 1:56 PM |
| Esperion Therapeutics, inc (ESPR) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 4 at 12:16 AM |
| Esperion Therapeutics (ESPR) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 3 at 2:15 PM |
| ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update
finance.yahoo.com - August 3 at 8:09 AM |
| Earnings Preview: Esperion Therapeutics (ESPR) Q2 Earnings Expected to Decline
finance.yahoo.com - July 27 at 7:24 PM |
| Esperion to Participate in Upcoming Virtual Investor Conference
finance.yahoo.com - July 27 at 9:23 AM |
|
 | Esperion Therapeutics, Inc. Common Stock (ESPR)
nasdaq.com - July 16 at 11:56 PM |
| The Esperion Therapeutics (NASDAQ:ESPR) Share Price Is Up 68% And Shareholders Are Holding On
nasdaq.com - July 14 at 11:28 AM |
| Esperion to Report Second Quarter 2021 Financial Results August 3, 2021
finance.yahoo.com - July 13 at 9:20 AM |
| ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer
finance.yahoo.com - June 28 at 12:45 PM |
 | ESPR Jul 2021 12.500 put
uk.finance.yahoo.com - June 23 at 2:45 PM |
| ESPR Jul 2021 30.000 put
uk.finance.yahoo.com - June 23 at 9:22 AM |
| Why Is Esperion Therapeutics (ESPR) Up 6.4% Since Last Earnings Report?
finance.yahoo.com - June 3 at 2:44 PM |
| Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21
finance.yahoo.com - May 15 at 1:43 PM |
| Daily – Vickers Top Buyers & Sellers for 05/10/2021
finance.yahoo.com - May 11 at 9:45 AM |
| Analysts Just Slashed Their Esperion Therapeutics, Inc. (NASDAQ:ESPR) EPS Numbers
finance.yahoo.com - May 9 at 9:35 AM |
 | Esperion Therapeutics, Inc. (ESPR) CEO Timothy Mayleben on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 1:45 PM |
| Why Esperion Therapeutics Plummeted Nearly 22% Today
finance.yahoo.com - May 5 at 10:44 PM |
| Mid-Day Market Update: Crude Oil Rises 1%; Esperion Therapeutics Shares Drop Following Q1 Results
markets.businessinsider.com - May 5 at 5:43 PM |
 | Esperion Stock Plummets On Wider Than Expected Q1 Earnings Loss; Analysts Move To Sidelines
msn.com - May 5 at 5:43 PM |
| Where Esperion Therapeutics Stands With Analysts
markets.businessinsider.com - May 5 at 12:27 PM |
| Esperion (ESPR) Q1 Earnings Miss, Lower Drug Price Hits Sales
finance.yahoo.com - May 5 at 12:27 PM |
